Latest inventions in science and technology Chimeric Antigen Receptor T-cell (CAR-T Cell) Therapy The Technology Development Board signed an agreement under an Indo-Singapore joint venture to develop a treatment using CAR-T cell therapy for multiple myeloma, a type of incurable blood cancer. About CAR-T Cell Therapy CAR-T cell therapy is often referred to as a "living drug" because it utilizes the patient's own living immune cells, specifically T-cells. This is a type of immunotherapy in which T-cells are genetically modified and transformed into powerful cancer-fighting cells called CAR-T cells. T-cells are a type of white blood cell that plays a vital role in destroying harmful or abnormal cells in the body. In this therapy, T-cells are first collected from the patient's blood and are then modified in a laboratory by inserting a gene that creates a special artificial receptor called a Chimeric Antigen Receptor (CAR). After modification, these engineered CAR-T cells are infused back into the patient's body to identify and attack cancer cells more effectively. CARs are specially designed proteins that help T-cells identify, bind to, and destroy specific proteins found on the surface of cancer cells.
